These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9157218)

  • 21. [Neopterin variations during the menstrual cycle].
    Haas R; Gerstner L
    Allerg Immunol (Leipz); 1986; 32(3):169-73. PubMed ID: 2947440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application.
    Wachter H; Fuchs D; Hausen A; Reibnegger G; Werner ER
    Adv Clin Chem; 1989; 27():81-141. PubMed ID: 2667296
    [No Abstract]   [Full Text] [Related]  

  • 23. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.
    Fuchs D; Hausen A; Reibnegger G; Werner ER; Dierich MP; Wachter H
    Immunol Today; 1988 May; 9(5):150-5. PubMed ID: 3076770
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma levels of granulocyte elastase and neopterin in patients with MOF.
    Pacher R; Redl H; Woloszczuk W
    Prog Clin Biol Res; 1989; 308():683-8. PubMed ID: 2789398
    [No Abstract]   [Full Text] [Related]  

  • 25. Juvenile dermatomyositis (JDMS): new clues to diagnosis and pathogenesis.
    Pachman LM
    Clin Exp Rheumatol; 1994; 12 Suppl 10():S69-73. PubMed ID: 7955631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neopterin and creatinine relationships in liver and kidney transplants.
    Takasugi M; Ward HJ; Colonna J; Busuttil RW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2056-8. PubMed ID: 2652673
    [No Abstract]   [Full Text] [Related]  

  • 27. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis.
    Roux S; Seelig HP; Meyer O
    J Rheumatol; 1998 Feb; 25(2):395-6. PubMed ID: 9489847
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis.
    Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Akiyama M
    J Dermatol Sci; 2019 Oct; 96(1):50-52. PubMed ID: 31444014
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum levels of interferon α do not correlate with disease activity in patients with dermatomyositis/polymyositis.
    Król P; Kryštůfková O; Polanská M; Mann H; Klein M; Beran O; Vencovský J
    Ann Rheum Dis; 2011 May; 70(5):879-80. PubMed ID: 21068097
    [No Abstract]   [Full Text] [Related]  

  • 31. Inflammatory myopathies--a clinicopathologic study.
    Radhakrishnan VV; Nair MD; Kuruvilla A; Radhakrishnan K
    Indian J Pathol Microbiol; 1997 Jul; 40(3):315-20. PubMed ID: 9354000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum neopterin, bacteremia and viral antibodies in dilated cardiomyopathy].
    Aleksandrova LZ; Nasonov EL; Chankov SV; Samsonov MIu; Ovtrakht NV; Titov VN
    Ter Arkh; 1994; 66(9):69-70. PubMed ID: 7992219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
    Hiruma S; Ohtsuka K; Satou T; Furuta T; Kimura M; Hashimoto S
    Rinsho Byori; 1998 Feb; 46(2):168-75. PubMed ID: 9528342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polymyositis and dermatomyositis in adults].
    Matsubara S
    Ryoikibetsu Shokogun Shirizu; 2001; (35):284-90. PubMed ID: 11555932
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunological aspects of polymyositis].
    Takayanagi T; Honda H
    No To Shinkei; 1983 Jun; 35(6):525-33. PubMed ID: 6354219
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of cyclosporine A dosage and metabolism in liver and heart transplant recipients.
    Hamilton G; Mühlbacher F; Roth E; Wolf I; Piza F; Havel M; Laczkovics A; Schindler J; Wolosczuk W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1706-8. PubMed ID: 3547878
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neopterin, a marker for activation of cellular immunity].
    Lambin P; Devillierre N
    Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):415-26. PubMed ID: 2285449
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevated D-erythro-neopterin levels in intensive care patients with septic complications.
    Strohmaier W; Redl H; Schlag G; Inthorn D
    Prog Clin Biol Res; 1987; 236B():59-66. PubMed ID: 3615478
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients.
    Shirafuji T; Hamaguchi H; Higuchi M; Kanda F
    Muscle Nerve; 2009 May; 39(5):586-90. PubMed ID: 19347930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
    Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
    Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.